期刊文献+

聚对二氧环己酮血管外支架抑制移植静脉内膜增生的机制 被引量:2

Inhibitory effect of polydioxanone suture external stent on the vein graft neointima thickening and the possible mechanism
原文传递
导出
摘要 目的构建可降解性聚对二氧环己酮(PDS)血管外支架抑制移植静脉内膜增生的动物模型,探讨PDS外支架抑制移植静脉内膜增生的作用及其机制。方法建立兔颈外静脉移植模型,24只新西兰大白兔分为单纯移植组(n=12)和PDS外支架组(n=12)。术后4周及12周取出移植静脉,测量移植静脉内膜、中层面积及厚度,免疫组织化学法和实时荧光定量逆转录-聚合酶链反应(RT-PCR)法检测增殖细胞核抗原(PCNA)、转化生长因子-β1(TGF-β1)和肾素-血管紧张素Ⅱ受体1(AT1R)表达。结果24只兔均存活,移植血管全部通畅。外支架组中膜面积、内膜面积、中膜厚度、内膜厚度各值皆小于单纯移植组,差异有统计学意义(P〈0.05)。免疫组织化学与RT—PCR检测表明血管外支架组TGF-β1在外膜中过度表达,而中膜和内膜表达减少。术后4周,外支架组AT1R表达水平低于对照组,12周时,两组AT1R表达水平都降低,差异无统计学意义(P〉0.05)。结论大孔隙、非限制性PDS血管外支架通过形成新生外膜、调节细胞因子再分布等机制有效地抑制内膜和中膜的增生,其用于抑制移植静脉内膜增生是可行的。 Objective To evaluate the effect of a biodegradable external stent on intimal vein graft thickening in an arteriovenous bypass grafting model, and study its possible mechanism. Methods Twenty-four rabbits underwent carotid interposition bypass via ipsilateral jugular vein. Half received the polydioxanone stent (PDS group) and half a simple vein graft (controls). Group subsets received external stent removal or sham-control exploration at 4th and 12th week. Each of the specimens was detected for pathological and molecular biological examination. Results At 4th and 12th week the PDS group had significantly less medial and intimal thickening than the control group ( P 〈 0.05 ), and there were fewer proliferating smooth muscle cells and extra cellular matrix formation than the control group at every interval. The proliferating cell nuclear antigen (PCNA) and angiotensin Ⅱ type 1 receptor (AT1 R) were over-expressed in the tunica media and intima in control group. The transforming growth factor-β1 (TGF-β1) was expressed mostly in adventitia in PDS group. Conclusion An macro-porous nonrestrictive, PDS external stent can ef fectively inhibit the intimal hyperplasia in vein bypass grafts, which might be contributed to the re-distrlbution of TGF-β1 and AT1R.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第9期1448-1451,I0003,共5页 Chinese Journal of Experimental Surgery
基金 中国博士后基金资助项目(20070410733) 江苏省“333工程”科研项目市级资助项目(CAE01001436)
关键词 静脉移植 内膜增生 转化生长因子-Β1 肾素-血管紧张素Ⅱ受体1 Vein graft Intimal thickening TGF-β1 AT1R
  • 相关文献

参考文献10

  • 1Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome : angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol. 1996,28:616-626.
  • 2Angelini GD, Izzat MB, Bryan AJ,et al. External stenting reduces early medial and neointimal thickening in a pig model of arteriovenous by- pass grafting. J Thorac C ardiovasc Surg, 1996,1 !2:79-84.
  • 3Jeremy JY, Bulbulia R, Johnson JL, et al. A bioabsorbabte ( polygla- ctin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening. J Thrac Cardiovasc Surg,2004,127 : 1766-1772.
  • 4刘冰,游庆军,胡国强,王文祖.仿生型人工小血管支架的构建与体外力学研究[J].中华实验外科杂志,2009,26(5):567-569. 被引量:3
  • 5Qingjun Y. Construction of small-caliber, polydiaxanone cyclohexanone vascular stents. Cell Biochem Biophys ,2010,57:35-43.
  • 6Bunt TJ. Vascular graft infections:an update. Cardiovasc Surg,2001,9: 225 -233.
  • 7George SJ, Izzat MB, Gadsdon P, et al. Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis,2001,155: 329-336.
  • 8Stracke S, Konner K, Kostlin I, et al. Increased expression of TGF-β1 and IGF-1 in inflammatory stenotic lesions of hemodialysis fistulas. Kid- ney Int,2002,61:1011-1019.
  • 9Chamberlain J, Gunn J, Francis D, et al. TGF-β is active, and correlates with activators of TGF beta, following porcine coronary angioplasty. Car- diovasc Res ,2001,50 : 125-136.
  • 10Nishimoto M,Takai S, Sawada Y, et al. Chymase-dependent angiotensin I formation in the saphenous vein versus the intemal thoracic artery. J Thorac Cardiovasc Surg,2001,121:729-734.

二级参考文献9

  • 1张燕忠,刘阳,曹谊林,张柏根.组织工程学方法体外构建血管的研究[J].中华实验外科杂志,2005,22(1):39-40. 被引量:3
  • 2Hsu S, Kambic H. On matching compliance between canine carotid arteries and polyurethane grafts. Artificial Organs, 1997,21 : 1247-1254.
  • 3Makela P, Pohjonen T, Tonnala P, et al. Strength retention properties of self-reinforced poly L-lactide (SR-PLLA) sutures compared with polyglyconate(Maxon) and polydioxanone(PDS) sutures. An in vitro study. Biomaterials ,2002,23:2587-2592.
  • 4Hodde JP, Record RD, Liang HA, et al. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium, 2001,8 : 11-24.
  • 5Qiu Y, Tarbell JM. Computational simulation of flow in the end-to-end anastomosis of a rigid graft and a compliant artery. Asaio J, 1996,42 : 702-710.
  • 6Sonoda H, Urayama S, Takamizawa K, et al. Compliant design of artificial graft:Compliance determination by new digitalx-ray imaging system-based method. J Biomed Mater Res ,2002,60 : 191-195.
  • 7Tai NR, Salacinski H J, Edwards A, et al. Compliance properties of conduits used in vascular reconstruction. Brit J Surg,2000,87:1516- 1524.
  • 8刘生和,王建广,范存义,莫秀梅.小肠黏膜下层粘接交联制作小口径血管支架[J].中国组织工程研究与临床康复,2007,11(32):6374-6378. 被引量:6
  • 9游庆军,肖明第,段亮,王峰,吴玉玉,朱斌.仿生型人工小血管支架的构建与体内降解研究[J].中华实验外科杂志,2008,25(12):1621-1623. 被引量:4

共引文献2

同被引文献31

  • 1Deb S, Wijeysandera HC, Ko DT, et al. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revaseularization : a systematic review[ J ]. JAMA ,2013,310 ( 19 ) :2086-2095.
  • 2Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease :5-year follow-up of the randomised, clinical SYNTAX trial [ J ]. Lancet, 2013, 381 (9867) :629-638.
  • 3. Harskamp RE, Lopes RD, Baisden CE,et at. Saphenous vein graft fail- ure after coronary artery bypass surgery: pathophysiology, manage-ment, and future directions [ J ]. Ann Surg,2013,257 (5) :824-833.
  • 4Parsonnet Y, Lari AA,Shah IH. New stent for support of veins in arte- rial grafts [ J ]. Arch Surg, 1963,87:696-702.
  • 5Desai M, Mirzay-Razzaz J, yon Delft D, et al. Inhibition of neointimal formalion and hyperplasia in vein grafts by external stent/sheath[ J]. Vase Meal,2010,15(4) :287-297.
  • 6George S J, Wan S, Hu J, et al. Sustained reduction of vein grat) neoint- ima formatior by ex vivo TIMP-3 gene therapy[ J]. Circulation,2011, 124( 11 Suppl) :S135-S142.
  • 7Hu J, Liu J, Huang Y, et aL Bone morphogenie protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revasculafization[ J]. Ann Thorae Surg,2013,95 (4) : 1331- 1339.
  • 8Longchamp A, Alonso F, Dubuis C,et al. The use of external mesh re- inforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins[ J]. Biomaterials ,2014,35 (9) :2588-2599.
  • 9Berard X, D6glise S, Alonso F, et al. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins[ J]. J Vasc Surg, 2013,57(5) :1371-1382.
  • 10Cheng J, Wang Y, Ma Y, et al. The mechanical stress-activated sernm- glucocorticoid--regulated kinase 1 contributes to neointima formation in vein grafts [ J ]. Circ Res ,2010,107 ( 10 ) : 1265-1274.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部